Drugs / BC LisPram
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04972175 | Jul 2021 → Jun 2022 | type 1 diabetes mellitus | Michael Tsoukas | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BC LisPram | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04972175 ↗ |
| Route | Subcutaneous | “Subcutaneous-delivery of BC LisPram using pump therapy.” NCT04972175 ↗ |